Ho M, Sexton M M, Tongtawe P, Looareesuwan S, Suntharasamai P, Webster H K
Department of Microbiology and Infectious Diseases, University of Calgary, Canada.
J Infect Dis. 1995 Sep;172(3):838-44. doi: 10.1093/infdis/172.3.838.
In vivo interleukin (IL)-2, IL-4, IL-10, and interferon (IFN)-gamma production was measured at the mRNA transcript and protein levels in patients acutely infected with Plasmodium falciparum and during convalescence. Both IL-10 and IFN-gamma but not IL-2 were produced regardless of the patients' clinical severity. IL-4 production was variable. Circulating IFN-gamma and IL-10 were significantly higher in patients with severe disease (P < .01 and .001, respectively). In vitro stimulation of peripheral blood mononuclear cells (PBMC) by malarial antigens during acute infection showed that although there was no lymphoproliferation, the cells could produce IL-10 and IFN-gamma. Recombinant human IL-10 completely abolished in vitro tumor necrosis factor (TNF)-alpha production in response to malarial antigens, as well as the antigen-specific proliferative response of convalescent patients. However, anti-IL-10 was insufficient to restore proliferation of PBMC from acutely infected patients. These findings suggest that IL-10 may have an important negative feedback action on the production of inflammatory cytokines in acute falciparum malaria without contributing to the defect in antigen-specific proliferation.
在恶性疟原虫急性感染患者及恢复期患者中,在mRNA转录水平和蛋白质水平上检测了体内白细胞介素(IL)-2、IL-4、IL-10和干扰素(IFN)-γ的产生情况。无论患者的临床严重程度如何,均可产生IL-10和IFN-γ,但不产生IL-2。IL-4的产生情况存在差异。重症患者循环中的IFN-γ和IL-10显著更高(分别为P <.01和.001)。急性感染期间用疟疾抗原体外刺激外周血单个核细胞(PBMC)显示,虽然没有淋巴细胞增殖,但细胞可产生IL-10和IFN-γ。重组人IL-10完全消除了体外对疟疾抗原产生的肿瘤坏死因子(TNF)-α,以及恢复期患者的抗原特异性增殖反应。然而,抗IL-10不足以恢复急性感染患者PBMC的增殖。这些发现表明,IL-10可能对急性恶性疟疾中炎性细胞因子的产生具有重要的负反馈作用,而对抗原特异性增殖缺陷无影响。